NextCure, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 2.67 M | $2.06 M | 0.00% | 9.55% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 2.30 M | $1.78 M | 0.00% | 8.23% |
| PFIZER INC | 02/14/2025 | 1.46 M | $1.89 M | 100.00% | 5.21% |
| CITIGROUP INC | 02/12/2025 | 1.39 M | $1.07 M | 100.00% | 4.97% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.14 M | $879,865 | 0.00% | 4.08% |
| VANGUARD GROUP INC | 02/11/2025 | 987,324 | $761,227 | 0.00% | 3.53% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 727,579 | $560,963 | -0.31% | 2.60% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 700,000 | $539,700 | 7.30% | 2.50% |
| CABLE CAR CAPITAL LLC | 02/14/2025 | 615,878 | $474,842 | 0.00% | 2.20% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 519,300 | $400,380 | 27.91% | 1.86% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 488,440 | $375,000 | 0.00% | 1.75% |
| 01/29/2025 | 403,698 | $311,251 | 100.00% | 1.44% | |
| FEDERATED HERMES, INC. | 02/13/2025 | 315,180 | $243,004 | -1.97% | 1.13% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 273,536 | $210,896 | -1.06% | 0.98% |
| CARDIFF PARK ADVISORS, LLC | 02/14/2025 | 262,000 | $202,002 | 0.00% | 0.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 233,914 | $180,397 | 4.55% | 0.84% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 185,936 | $143,357 | -66.56% | 0.66% |
| MACQUARIE GROUP LTD | 02/14/2025 | 150,000 | $116,000 | 0.00% | 0.54% |
| SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 130,000 | $100,230 | 0.00% | 0.46% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 120,012 | $92,529 | 0.00% | 0.43% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 107,672 | $83,015 | 0.00% | 0.38% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 104,000 | $80,184 | 4.00% | 0.37% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 85,853 | $66,193 | 0.00% | 0.31% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 67,600 | $52,120 | -4.25% | 0.24% |
| BARCLAYS PLC | 02/13/2025 | 67,518 | $52,000 | 0.00% | 0.24% |
| MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 58,259 | $44,918 | 0.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 48,186 | $37,151 | 100.00% | 0.17% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 42,517 | $32,781 | -41.05% | 0.15% |
| IEQ CAPITAL, LLC | 02/03/2025 | 37,342 | $28,791 | 0.00% | 0.13% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 25,000 | $19,275 | 100.00% | 0.09% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 22,951 | $18,000 | 100.00% | 0.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 21,800 | $16,807 | -8.40% | 0.08% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 20,198 | $15,573 | 87.47% | 0.07% |
| HSBC HOLDINGS PLC | 02/14/2025 | 17,363 | $13,717 | 0.00% | 0.06% |
| XTX TOPCO LTD | 02/13/2025 | 13,577 | $10,468 | 100.00% | 0.05% |
| UBS GROUP AG | 02/14/2025 | 4,202 | $3,240 | -23.12% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,191 | $1,631 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 805 | $621 | -0.25% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 658 | $508 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 385 | $297 | 0.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| HARBOURVEST PARTNERS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACUITAS INVESTMENTS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NextCure, Inc. institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of NextCure, Inc.. The most heavily invested institutionals were:
Sofinnova Investments, Inc.: 2.67 M
Affinity Asset Advisors, LLC: 2.3 M
PFIZER INC: 1.46 M
CITIGROUP INC: 1.39 M
ORBIMED ADVISORS LLC: 1.14 M
VANGUARD GROUP INC: 987,324
57.32% of NextCure, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.50 M shares in the last 24 months. This purchase volume represents approximately $16.10 M in transactions.